JPH0410452B2 - - Google Patents
Info
- Publication number
- JPH0410452B2 JPH0410452B2 JP58131656A JP13165683A JPH0410452B2 JP H0410452 B2 JPH0410452 B2 JP H0410452B2 JP 58131656 A JP58131656 A JP 58131656A JP 13165683 A JP13165683 A JP 13165683A JP H0410452 B2 JPH0410452 B2 JP H0410452B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- hydrochloride
- methyl
- cyclohexenone
- carried out
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 claims description 26
- 239000003054 catalyst Substances 0.000 claims description 8
- 238000006114 decarboxylation reaction Methods 0.000 claims description 6
- UCUUFSAXZMGPGH-UHFFFAOYSA-N penta-1,4-dien-3-one Chemical class C=CC(=O)C=C UCUUFSAXZMGPGH-UHFFFAOYSA-N 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 description 23
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 21
- -1 amino acid compounds Chemical class 0.000 description 18
- FWFSEYBSWVRWGL-UHFFFAOYSA-N cyclohex-2-enone Chemical compound O=C1CCCC=C1 FWFSEYBSWVRWGL-UHFFFAOYSA-N 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- 238000002844 melting Methods 0.000 description 12
- 230000008018 melting Effects 0.000 description 12
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 10
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 9
- 229940024606 amino acid Drugs 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 238000000862 absorption spectrum Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- BZKFMUIJRXWWQK-UHFFFAOYSA-N Cyclopentenone Chemical compound O=C1CCC=C1 BZKFMUIJRXWWQK-UHFFFAOYSA-N 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- KLTVSWGXIAYTHO-UHFFFAOYSA-N 1-Octen-3-one Chemical compound CCCCCC(=O)C=C KLTVSWGXIAYTHO-UHFFFAOYSA-N 0.000 description 4
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 125000001246 bromo group Chemical group Br* 0.000 description 3
- DFLRGCFWSRELEL-UHFFFAOYSA-N cyclobut-2-en-1-one Chemical compound O=C1CC=C1 DFLRGCFWSRELEL-UHFFFAOYSA-N 0.000 description 3
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical class O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 125000006017 1-propenyl group Chemical group 0.000 description 2
- TYDSIOSLHQWFOU-UHFFFAOYSA-N 2-cyclohexylidenecyclohexan-1-one Chemical compound O=C1CCCCC1=C1CCCCC1 TYDSIOSLHQWFOU-UHFFFAOYSA-N 0.000 description 2
- KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical compound CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 description 2
- SHOJXDKTYKFBRD-UHFFFAOYSA-N 4-Methyl-3-penten-2-one, 9CI Chemical compound CC(C)=CC(C)=O SHOJXDKTYKFBRD-UHFFFAOYSA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- MUDSDYNRBDKLGK-UHFFFAOYSA-N 4-methylquinoline Chemical compound C1=CC=C2C(C)=CC=NC2=C1 MUDSDYNRBDKLGK-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
- HCUARRIEZVDMPT-UHFFFAOYSA-N Indole-2-carboxylic acid Chemical compound C1=CC=C2NC(C(=O)O)=CC2=C1 HCUARRIEZVDMPT-UHFFFAOYSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Chemical compound OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 229960004050 aminobenzoic acid Drugs 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- IADUEWIQBXOCDZ-UHFFFAOYSA-N azetidine-2-carboxylic acid Chemical compound OC(=O)C1CCN1 IADUEWIQBXOCDZ-UHFFFAOYSA-N 0.000 description 2
- ODWXUNBKCRECNW-UHFFFAOYSA-M bromocopper(1+) Chemical compound Br[Cu+] ODWXUNBKCRECNW-UHFFFAOYSA-M 0.000 description 2
- 230000000911 decarboxylating effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 229960002591 hydroxyproline Drugs 0.000 description 2
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- SASNBVQSOZSTPD-UHFFFAOYSA-N n-methylphenethylamine Chemical compound CNCCC1=CC=CC=C1 SASNBVQSOZSTPD-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- WRHZVMBBRYBTKZ-UHFFFAOYSA-N pyrrole-2-carboxylic acid Chemical compound OC(=O)C1=CC=CN1 WRHZVMBBRYBTKZ-UHFFFAOYSA-N 0.000 description 2
- JHHZLHWJQPUNKB-UHFFFAOYSA-N pyrrolidin-3-ol Chemical compound OC1CCNC1 JHHZLHWJQPUNKB-UHFFFAOYSA-N 0.000 description 2
- SMUQFGGVLNAIOZ-UHFFFAOYSA-N quinaldine Chemical compound C1=CC=CC2=NC(C)=CC=C21 SMUQFGGVLNAIOZ-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- APJYDQYYACXCRM-UHFFFAOYSA-N tryptamine Chemical compound C1=CC=C2C(CCN)=CNC2=C1 APJYDQYYACXCRM-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- FVQDAMVODWHNOJ-VIFPVBQESA-N (2s)-2-(carboxymethylamino)-3-phenylpropanoic acid Chemical compound OC(=O)CN[C@H](C(O)=O)CC1=CC=CC=C1 FVQDAMVODWHNOJ-VIFPVBQESA-N 0.000 description 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- OSJVTYVKQNOXPP-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline-2-carboxylic acid Chemical compound C1=CC=C2NC(C(=O)O)CCC2=C1 OSJVTYVKQNOXPP-UHFFFAOYSA-N 0.000 description 1
- KEIFWROAQVVDBN-UHFFFAOYSA-N 1,2-dihydronaphthalene Chemical compound C1=CC=C2C=CCCC2=C1 KEIFWROAQVVDBN-UHFFFAOYSA-N 0.000 description 1
- UUVDQMYRPUHXPB-UHFFFAOYSA-N 1,3-benzothiazole-2-carboxylic acid Chemical compound C1=CC=C2SC(C(=O)O)=NC2=C1 UUVDQMYRPUHXPB-UHFFFAOYSA-N 0.000 description 1
- IJVLVRYLIMQVDD-UHFFFAOYSA-N 1,3-thiazole-2-carboxylic acid Chemical compound OC(=O)C1=NC=CS1 IJVLVRYLIMQVDD-UHFFFAOYSA-N 0.000 description 1
- FUPIVZHYVSCYLX-UHFFFAOYSA-N 1,4-dihydronaphthalene Chemical compound C1=CC=C2CC=CCC2=C1 FUPIVZHYVSCYLX-UHFFFAOYSA-N 0.000 description 1
- LTYLUDGDHUEBGX-UHFFFAOYSA-N 1-(cyclohexen-1-yl)ethanone Chemical compound CC(=O)C1=CCCCC1 LTYLUDGDHUEBGX-UHFFFAOYSA-N 0.000 description 1
- NKWCGTOZTHZDHB-UHFFFAOYSA-N 1h-imidazol-1-ium-4-carboxylate Chemical compound OC(=O)C1=CNC=N1 NKWCGTOZTHZDHB-UHFFFAOYSA-N 0.000 description 1
- UNQHGXLQKSZYQU-UHFFFAOYSA-N 2-(thiophen-2-ylamino)acetic acid Chemical compound OC(=O)CNC1=CC=CS1 UNQHGXLQKSZYQU-UHFFFAOYSA-N 0.000 description 1
- VJQOUHZVZWHSNW-UHFFFAOYSA-N 2-(thiophen-3-ylamino)acetic acid Chemical compound OC(=O)CNC=1C=CSC=1 VJQOUHZVZWHSNW-UHFFFAOYSA-N 0.000 description 1
- CNIWLQLCALZLEQ-UHFFFAOYSA-N 2-[2-(4-hydroxyphenyl)ethylamino]acetic acid Chemical compound OC(=O)CNCCC1=CC=C(O)C=C1 CNIWLQLCALZLEQ-UHFFFAOYSA-N 0.000 description 1
- NYSYNXRPXJZYFY-UHFFFAOYSA-N 2-cyclopentylidenecyclopentan-1-one Chemical compound O=C1CCCC1=C1CCCC1 NYSYNXRPXJZYFY-UHFFFAOYSA-N 0.000 description 1
- FKMGZMDLSNOJPQ-UHFFFAOYSA-N 2-methylhept-2-en-4-one Chemical compound CCCC(=O)C=C(C)C FKMGZMDLSNOJPQ-UHFFFAOYSA-N 0.000 description 1
- VYTPDQSCOXJDJM-UHFFFAOYSA-N 2-methylidenecyclohexan-1-one Chemical compound C=C1CCCCC1=O VYTPDQSCOXJDJM-UHFFFAOYSA-N 0.000 description 1
- SLRKFRUSEKUSAF-UHFFFAOYSA-N 2-methylidenecyclopentan-1-one Chemical compound C=C1CCCC1=O SLRKFRUSEKUSAF-UHFFFAOYSA-N 0.000 description 1
- MLKBDUKURHYFKP-UHFFFAOYSA-N 2-methylidenecyclopentane-1,3-dione Chemical compound C=C1C(=O)CCC1=O MLKBDUKURHYFKP-UHFFFAOYSA-N 0.000 description 1
- LVQRNIHYWJWRMN-UHFFFAOYSA-N 2-phenanthren-9-ylacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC3=CC=CC=C3C2=C1 LVQRNIHYWJWRMN-UHFFFAOYSA-N 0.000 description 1
- MMTBDIDPDFBJIC-UHFFFAOYSA-N 2-propan-2-ylidenecyclohexan-1-one Chemical compound CC(C)=C1CCCCC1=O MMTBDIDPDFBJIC-UHFFFAOYSA-N 0.000 description 1
- XFDUHJPVQKIXHO-UHFFFAOYSA-N 3-aminobenzoic acid Chemical compound NC1=CC=CC(C(O)=O)=C1 XFDUHJPVQKIXHO-UHFFFAOYSA-N 0.000 description 1
- KKYSBGWCYXYOHA-UHFFFAOYSA-N 3-methylthiopropylamine Chemical compound CSCCCN KKYSBGWCYXYOHA-UHFFFAOYSA-N 0.000 description 1
- FBTSQILOGYXGMD-LURJTMIESA-N 3-nitro-L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C([N+]([O-])=O)=C1 FBTSQILOGYXGMD-LURJTMIESA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- IADUEWIQBXOCDZ-VKHMYHEASA-N Azetidine-2-carboxylic acid Natural products OC(=O)[C@@H]1CCN1 IADUEWIQBXOCDZ-VKHMYHEASA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- YDQJXVYGARVLRT-UHFFFAOYSA-N Lepidine Natural products C=1C=CC(CC=2NC=CN=2)=CC=1OC=1C(OC)=CC=CC=1CC1=NC=CN1 YDQJXVYGARVLRT-UHFFFAOYSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000001118 alkylidene group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- YBCKTQFKZPWBNP-UHFFFAOYSA-N cyclododec-2-en-1-one Chemical compound O=C1CCCCCCCCCC=C1 YBCKTQFKZPWBNP-UHFFFAOYSA-N 0.000 description 1
- QCRFMSUKWRQZEM-UHFFFAOYSA-N cycloheptanol Chemical compound OC1CCCCCC1 QCRFMSUKWRQZEM-UHFFFAOYSA-N 0.000 description 1
- CGZZMOTZOONQIA-UHFFFAOYSA-N cycloheptanone Chemical compound O=C1CCCCCC1 CGZZMOTZOONQIA-UHFFFAOYSA-N 0.000 description 1
- KCTVMJDQWLQXHT-UHFFFAOYSA-N cyclohex-2-en-1-one Chemical class O=C1CCCC=C1.O=C1CCCC=C1 KCTVMJDQWLQXHT-UHFFFAOYSA-N 0.000 description 1
- OANSOJSBHVENEI-UHFFFAOYSA-N cyclohexene-1-carbaldehyde Chemical compound O=CC1=CCCCC1 OANSOJSBHVENEI-UHFFFAOYSA-N 0.000 description 1
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical class O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 1
- GGRQLKPIJPFWEZ-UHFFFAOYSA-N cycloprop-2-en-1-one Chemical class O=C1C=C1 GGRQLKPIJPFWEZ-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- HCIBTBXNLVOFER-UHFFFAOYSA-N diphenylcyclopropenone Chemical compound O=C1C(C=2C=CC=CC=2)=C1C1=CC=CC=C1 HCIBTBXNLVOFER-UHFFFAOYSA-N 0.000 description 1
- CZZYITDELCSZES-UHFFFAOYSA-N diphenylmethane Chemical compound C=1C=CC=CC=1CC1=CC=CC=C1 CZZYITDELCSZES-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- QNRXNRGSOJZINA-UHFFFAOYSA-N indoline-2-carboxylic acid Chemical compound C1=CC=C2NC(C(=O)O)CC2=C1 QNRXNRGSOJZINA-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- HXEACLLIILLPRG-RXMQYKEDSA-N l-pipecolic acid Natural products OC(=O)[C@H]1CCCCN1 HXEACLLIILLPRG-RXMQYKEDSA-N 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- RUMOYJJNUMEFDD-UHFFFAOYSA-N perillyl aldehyde Chemical compound CC(=C)C1CCC(C=O)=CC1 RUMOYJJNUMEFDD-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- HXEACLLIILLPRG-UHFFFAOYSA-N pipecolic acid Chemical compound OC(=O)C1CCCCN1 HXEACLLIILLPRG-UHFFFAOYSA-N 0.000 description 1
- GJLHPWURQTWXMF-UHFFFAOYSA-M potassium;3,4-dioxonaphthalene-1-sulfonate Chemical compound [K+].C1=CC=C2C(S(=O)(=O)[O-])=CC(=O)C(=O)C2=C1 GJLHPWURQTWXMF-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- DOYOPBSXEIZLRE-UHFFFAOYSA-N pyrrole-3-carboxylic acid Natural products OC(=O)C=1C=CNC=1 DOYOPBSXEIZLRE-UHFFFAOYSA-N 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Description
【発明の詳細な説明】
本発明はカルボキシル基を有する化合物の脱炭
酸反応に関する。更に詳しくは該脱炭酸反応にお
いて、触媒としてビニルケトン類を使用すること
からなる。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a decarboxylation reaction of a compound having a carboxyl group. More specifically, in the decarboxylation reaction, vinyl ketones are used as a catalyst.
従来、脱炭酸の容易な化合物は、直接加熱する
ことによつて脱炭酸反応が行なわれている。しか
し、直接加熱法では化合物自体が分解したりし
て、脱炭酸反応がうまくいかない等の場合は、溶
剤の存在下で行なわれることが多い。しかし、こ
の反応においても種々の欠点を有する。例えばア
ミノ酸化合物をテトラリンやシクロヘキサノール
の存在下で触媒に過酸化物を用いて脱炭酸を行う
反応(薬学雑誌,85巻,531頁,1965年)におい
ては、触媒として危険な過酸化物を使用するこ
と、収率が低いこと等の欠点を有する。また、ト
リプトフアンを微生物ミクロコツカス・ペルシト
レウスと接触させて脱炭酸を行う反応(フランス
特許第2239459号)においては、微生物の培養、
生成物の採取等に煩雑な操作を要すること等の欠
点を有する。また、9−フエナントリル酢酸を
240℃で24時間反応させて脱炭酸を行う反応
(Can.J.Chem.,56巻,5号,628頁,1978年)に
おいては、反応が高温で行なわれること、反応時
間が長いこと等の欠点を有する。また、ドデシル
酸を臭化銅当モルの存在下で320℃で脱炭酸を行
う反応(米国特許第4262157号)においては、反
応が高温で行なわれること、臭化銅を大量に使用
すること等の欠点を有する。また、チロシンをジ
フエニルメタンの存在下で260〜265℃で脱炭酸を
行う反応(Synthesis,475頁,1972年)において
は、反応が高温で行なわれること、収率が低いこ
と等の欠点を有する。 Conventionally, compounds that are easily decarboxylated have been decarboxylated by direct heating. However, if the decarboxylation reaction does not go well in the direct heating method because the compound itself decomposes, the decarboxylation reaction is often carried out in the presence of a solvent. However, this reaction also has various drawbacks. For example, in the reaction of decarboxylating amino acid compounds using peroxide as a catalyst in the presence of tetralin or cyclohexanol (Pharmaceutical Journal, Vol. 85, p. 531, 1965), a dangerous peroxide is used as a catalyst. It has drawbacks such as high yield and low yield. In addition, in the reaction in which tryptophan is brought into contact with the microorganism Micrococcus persitreus to decarboxylate it (French Patent No. 2239459), the culture of the microorganism,
It has drawbacks such as requiring complicated operations for collecting the product. In addition, 9-phenanthrylacetic acid
In the reaction in which decarboxylation is carried out by reacting at 240°C for 24 hours (Can.J.Chem., Vol. 56, No. 5, p. 628, 1978), the reaction is carried out at a high temperature, the reaction time is long, etc. It has the following disadvantages. In addition, in the reaction of decarboxylating dodecylic acid at 320°C in the presence of equivalent moles of copper bromide (US Pat. No. 4,262,157), the reaction is carried out at a high temperature, a large amount of copper bromide is used, etc. It has the following disadvantages. Furthermore, the reaction in which tyrosine is decarboxylated at 260 to 265° C. in the presence of diphenylmethane (Synthesis, p. 475, 1972) has drawbacks such as the reaction being carried out at a high temperature and the yield being low.
本発明は触媒として少量の安価で取扱いに安全
なビニルケトン類を使用すること、比較的低温で
反応が進行すること、収率が80%以上の高率であ
ること等の利点を有する。そして、本発明は広範
囲の化合物に対して適用しうることから、極めて
優れた画期的な発明であるといえる。 The present invention has advantages such as using a small amount of cheap and safe vinyl ketones as a catalyst, allowing the reaction to proceed at a relatively low temperature, and achieving a high yield of 80% or more. Since the present invention can be applied to a wide range of compounds, it can be said to be an extremely excellent and groundbreaking invention.
本発明を実施するに際して、脱炭酸させる化合
物としてはカルボキシル基を有する化合物が特に
限定なく挙げることができる。例えばアゼチジン
−2−カルボン酸、ピロリジン−2−カルボン
酸、ピペリジン−2−カルボン酸、ヘキサメチレ
ンイミン−2−カルボン酸、ピプラジン−2−カ
ルボン酸などの脂環状アミノカルボン酸類;ピロ
ール−2−カルボン酸、イミダゾール−5−カル
ボン酸、4−ピリドン−2,6−ジカルボン酸、
インドール−2−カルボン酸、2,3−ジヒドロ
インドール−2−カルボン酸、1,2,3,4−
テトラヒドロキノリン−2−カルボン酸、チアゾ
ール−2−カルボン酸、ベンゾチアゾール−2−
カルボン酸、ベンゾチアゾリン−2−カルボン酸
などの複素環状アミノカルボン酸類;グリシン、
アラニン、バリン、ロイシン、イソロイシン、ザ
ルコシン、アスパラギン、グルタミンのようなモ
ノアミノモノカルボン酸、セリン、トレオニン、
ホモセリンのようなオキシアミノ酸、メチオニ
ン、シスチンのようなイオウを含むアミノ酸、ア
ルギニン、リジン、オルニチンのような塩基性ア
ミノ酸、アスパラギン酸、グルタミン酸、N−カ
ルボキシメチルロイシンのような酸性アミノ酸な
どの脂肪族アミノ酸類;フエニルアラニン、チロ
シン、3−ニトロチロシン、N−カルボキシメチ
ルフエニルアラニン、N−カルボキシメチルチラ
ミンなどの芳香族環を有する脂肪族アミノ酸類;
トリプトフアン、ヒスチジン、2−チエニルグリ
シン、3−チエニルグリシンなど複素環を有する
脂肪族アミノ酸類;アントラニル酸、m−アミノ
安息香酸、p−アミノ安息香酸などの芳香族アミ
ノ酸類;等である。好ましくはα,β,γ位等に
アミノ基を有するカルボン酸化合物が好適であ
る。そして、これらの化合物は反応に関与しない
基を置換分として有していてもよい。このような
置換分としては例えばメチル、エチル、プロピル
のようなアルキル、メトキシ、エトキシ、プロポ
キシのようなアルコキシ、クロル、ブロムのよう
なハロゲン、ヒドロキシなどを挙げることができ
る。なお、これらの化合物は、立体異性体、例え
ば光学異性体であつても反応により影響を受ける
ことはない。 In carrying out the present invention, compounds having a carboxyl group can be mentioned as compounds to be decarboxylated without particular limitation. For example, alicyclic aminocarboxylic acids such as azetidine-2-carboxylic acid, pyrrolidine-2-carboxylic acid, piperidine-2-carboxylic acid, hexamethyleneimine-2-carboxylic acid, piprazine-2-carboxylic acid; pyrrole-2-carboxylic acid; acid, imidazole-5-carboxylic acid, 4-pyridone-2,6-dicarboxylic acid,
Indole-2-carboxylic acid, 2,3-dihydroindole-2-carboxylic acid, 1,2,3,4-
Tetrahydroquinoline-2-carboxylic acid, thiazole-2-carboxylic acid, benzothiazole-2-
Heterocyclic aminocarboxylic acids such as carboxylic acid and benzothiazoline-2-carboxylic acid; glycine,
Monoamino monocarboxylic acids like alanine, valine, leucine, isoleucine, sarcosine, asparagine, glutamine, serine, threonine,
Aliphatic amino acids such as oxyamino acids such as homoserine, sulfur-containing amino acids such as methionine and cystine, basic amino acids such as arginine, lysine and ornithine, and acidic amino acids such as aspartic acid, glutamic acid and N-carboxymethylleucine. Aliphatic amino acids having an aromatic ring such as phenylalanine, tyrosine, 3-nitrotyrosine, N-carboxymethylphenylalanine, N-carboxymethyltyramine;
These include aliphatic amino acids having a heterocycle such as tryptophan, histidine, 2-thienylglycine, and 3-thienylglycine; aromatic amino acids such as anthranilic acid, m-aminobenzoic acid, and p-aminobenzoic acid; and the like. Preferably, a carboxylic acid compound having an amino group at the α, β, or γ position is suitable. These compounds may also have a group that does not participate in the reaction as a substituent. Examples of such substituents include alkyl such as methyl, ethyl, and propyl, alkoxy such as methoxy, ethoxy, and propoxy, halogen such as chloro and bromo, and hydroxy. Note that even if these compounds are stereoisomers, for example optical isomers, they are not affected by the reaction.
本発明で使用させる触媒のビニルケトン類とし
ては、式
(式中、R1およびR2は有機基を示す。そして、
R1およびR2は一緒に結合して、環を形成しても
よい。)で示される化合物である。このような化
合物としては、下記の如き化合物を列挙すること
ができる。即ち、置換分としてメチル、エチル、
プロピルのようなアルキル、メトキシカルボニ
ル、エトキシカルボニル、ブトキシカルボニルの
ようなアルコキシカルボニル、クロル、ブロムの
ようなハロゲン、ビニル、1−プロペニル、イソ
プロペニルのようなアルケニル、フエニル、ヒド
ロキシ、アミノなどを有していてもよいΔ2−シ
クロアルケノン類;例えば2,3−ジフエニルシ
クロプロペノンのようなΔ2−シクロプロペノン
類、2,3−ジヒドロ−4−オキソ−Δ2−シク
ロブテノン、2,3,4,4−テトラクロロ−
Δ2−シクロブテノンのようなΔ2−シクロブテノ
ン類、Δ2−シクロペンテノン、3−メチル−Δ2
−シクロペンテノンのようなΔ2−シクロペンテ
ノン類、Δ2−シクロヘキセノン、2−メチル−
Δ2−シクロヘキセノン、3−メチル−Δ2−シク
ロヘキセノン、6−メチル−Δ2−シクロヘキセ
ノン、3−アミノ−Δ2−シクロヘキセノン、2
−エチル−4−エトキシカルボニル−3−メチル
−Δ2−シクロヘキセノン、4−エトキシカルボ
ニル−3−メチル−Δ2シクロヘキセノン、2,
6−ジメチル−Δ2−シクロヘキセノン、5−イ
ソプロペニル−2−メチル−Δ2−シクロヘキセ
ノン、2−クロロ−Δ2−シクロヘキセノン、3
−クロロ−Δ2−シクロヘキセノンのようなΔ2−
シクロヘキセノン類、Δ2−シクロドデセノン、
4−メチル−Δ2−シクロドデセノンのようなΔ2
−シクロドデセノン類など:置換分としてメチレ
ン、エチリデン、イソプロピリデンのようなアル
キリデン、シクロペンチリデン、シクロヘキシリ
デン、シクロヘプチリデンのようなシクロアルキ
リデンなどを有していてもよいシクロアルカノン
類;例えば2−メチレンシクロペンタノン、2−
メチレンシクロペンタン−1,3−ジオン、2−
シクロペンチリデンシクロペンタノンのようなシ
クロペンタノン類、2−メチレンシクロヘキサノ
ン、2−イソプロピリデンシクロヘキサノン、2
−シクロヘキシリデンシクロヘキサノンのような
シクロヘキサノン類など:置換分としてメチル、
エチル、プロピルのようなアルキル、クロル、ブ
ロムのようなハロゲン、ビニル、1−プロペニ
ル、イソプロペニルのようなアルケニル、フエニ
ルなどを有していてもよい1−アシルシクロヘキ
セン類;例えば1−ホルミルシクロヘキセン、1
−アセチルシクロヘキセン、4−イソプロペニル
−1−ホルミルシクロヘキセンなど:ナフトキノ
ン類、例えば1,2−ナフトキノン−4−スルホ
ン酸カリウムなど:脂肪族ビニルケトン類;例え
ば1−オクテン−3−オン、4−メチル−3−ペ
ンテン−2−オン、5−メチル−3−ヘキセン−
2−オン、6−メチル−5−ヘプテン−4−オン
など:を挙げることができる。触媒の使用量は原
料化合物に対して1〜10%V/W、好ましくは3
〜5%V/Wである。 The vinyl ketones of the catalyst used in the present invention have the formula (In the formula, R 1 and R 2 represent an organic group. And,
R 1 and R 2 may be joined together to form a ring. ). As such compounds, the following compounds can be enumerated. That is, methyl, ethyl,
Alkyl such as propyl, alkoxycarbonyl such as methoxycarbonyl, ethoxycarbonyl, butoxycarbonyl, halogen such as chlor, bromo, alkenyl such as vinyl, 1-propenyl, isopropenyl, phenyl, hydroxy, amino, etc. Δ 2 -cycloalkenones which may be present; for example Δ 2 -cyclopropenones such as 2,3-diphenylcyclopropenone, 2,3-dihydro-4-oxo-Δ 2 -cyclobutenone, 2,3 ,4,4-tetrachloro-
Δ 2 -cyclobutenones such as Δ 2 -cyclobutenone, Δ 2 -cyclopentenone, 3-methyl-Δ 2
-Δ 2 -cyclopentenones such as cyclopentenone, Δ 2 -cyclohexenone, 2-methyl-
Δ 2 -cyclohexenone, 3-methyl-Δ 2 -cyclohexenone, 6-methyl-Δ 2 -cyclohexenone, 3-amino-Δ 2 -cyclohexenone, 2
-ethyl-4-ethoxycarbonyl-3-methyl-Δ 2 -cyclohexenone, 4-ethoxycarbonyl-3-methyl-Δ 2 cyclohexenone, 2,
6-dimethyl-Δ 2 -cyclohexenone, 5-isopropenyl-2-methyl-Δ 2 -cyclohexenone, 2-chloro-Δ 2 -cyclohexenone, 3
−chloro−Δ 2 − Δ 2 − like cyclohexenone
Cyclohexenones, Δ 2 -cyclododecenone,
Δ 2 such as 4-methyl-Δ 2 -cyclododecenone
- Cyclododecenones, etc.: Cycloalkanones that may have alkylidene such as methylene, ethylidene, isopropylidene, cycloalkylidene such as cyclopentylidene, cyclohexylidene, cycloheptylidene, etc. as a substituent; 2-methylenecyclopentanone, 2-
methylenecyclopentane-1,3-dione, 2-
Cyclopentanones such as cyclopentylidenecyclopentanone, 2-methylenecyclohexanone, 2-isopropylidenecyclohexanone, 2
- Cyclohexanones such as cyclohexylidene cyclohexanone: methyl as a substituent,
1-acylcyclohexenes which may contain alkyl such as ethyl, propyl, halogen such as chlor, bromo, alkenyl such as vinyl, 1-propenyl, isopropenyl, phenyl, etc.; for example, 1-formylcyclohexene, 1
- Acetylcyclohexene, 4-isopropenyl-1-formylcyclohexene, etc.: Naphthoquinones, such as potassium 1,2-naphthoquinone-4-sulfonate, etc.: Aliphatic vinyl ketones, such as 1-octen-3-one, 4-methyl- 3-penten-2-one, 5-methyl-3-hexene-
Examples include 2-one, 6-methyl-5-hepten-4-one, and the like. The amount of catalyst used is 1 to 10% V/W, preferably 3% V/W based on the raw material compound.
~5% V/W.
反応は溶剤の存在下または不存在下で行なわれ
る。好ましくは溶剤の存在下で行なわれる。使用
される溶剤としては反応に関与しないものであれ
ば特に限定はなく、例えばシクロヘキサノール、
シクロヘプタノールのようなシクロアルカノール
類;テトラリン、Δ9,10−オクタリン、1,2−
ジヒドロナフタレン、1,4−ジヒドロナフタレ
ンのようなナフタレン類;シクロヘキサノン、シ
クロヘプタノンのようなシクロアルケノン類、キ
ノリン、キナルジン、レピジンのようなキノリン
類などを挙げることができる。反応温度は通常は
120〜250℃位、好ましくは140〜160℃位である。 The reaction is carried out in the presence or absence of a solvent. It is preferably carried out in the presence of a solvent. The solvent used is not particularly limited as long as it does not participate in the reaction, such as cyclohexanol,
Cycloalkanols such as cycloheptanol; tetralin, Δ 9,10 -octarine, 1,2-
Examples include naphthalenes such as dihydronaphthalene and 1,4-dihydronaphthalene; cycloalkenones such as cyclohexanone and cycloheptanone; and quinolines such as quinoline, quinaldine, and lepidine. The reaction temperature is usually
The temperature is about 120 to 250°C, preferably about 140 to 160°C.
反応は原料化合物を溶剤に懸濁もしくは溶解し
た後、触媒を加え、好ましくは窒素気流下で加熱
撹拌する。反応終了後、得られた生成物は反応混
合物より、例えばハロゲン化水素酸塩として析出
させるか、または蒸留に付すことによつて単離さ
れる。このようにして得られた生成物は必要に応
じて再結晶法、カラムクロマトグラフ法などに付
すことによつて精製される。 In the reaction, after suspending or dissolving the raw material compound in a solvent, a catalyst is added, and the mixture is heated and stirred, preferably under a nitrogen stream. After the reaction has ended, the product obtained is isolated from the reaction mixture, for example by precipitation as a hydrohalide salt or by distillation. The product thus obtained is purified by recrystallization, column chromatography, etc., if necessary.
次に実施例を挙げて本発明を更に詳細に説明す
るが、本発明はこれらの実施例に限定されるもの
ではない。 EXAMPLES Next, the present invention will be explained in more detail with reference to Examples, but the present invention is not limited to these Examples.
実施例 1
3−ヒドロキシピロリジン
4−ヒドロキシ−L−プロリン90gをシクロヘ
キサノール450mlに懸濁し、次いでΔ2−シクロヘ
キセノン4.5mlを加えて窒素気流下で加熱撹拌し
た。反応混合物を154±2℃で2時間撹拌すると
均一な溶液が得られた。反応終了後、反応混合物
を10℃に冷却し、次いでこれに酢酸エチル850ml
を加えて0〜5℃に冷却した。次いで、反応混合
物に塩化水素27.5gおよびイソプロパノール80ml
の混合液を内温5℃以下に保ちながら加えた。次
いで反応混合物を1時間撹拌し、析出物をろ取し
た。析出物をイソプロパノール90ml、次いで酢酸
エチル90mlで洗浄後、乾燥すると目的化合物の塩
酸塩76g(90%)が得られた。Example 1 3-Hydroxypyrrolidine 90 g of 4-hydroxy-L-proline was suspended in 450 ml of cyclohexanol, and then 4.5 ml of Δ 2 -cyclohexenone was added and the mixture was heated and stirred under a nitrogen stream. The reaction mixture was stirred at 154±2° C. for 2 hours, resulting in a homogeneous solution. After the reaction was completed, the reaction mixture was cooled to 10°C, and then 850ml of ethyl acetate was added to it.
was added and cooled to 0-5°C. Then, 27.5 g of hydrogen chloride and 80 ml of isopropanol were added to the reaction mixture.
The mixture was added while keeping the internal temperature below 5°C. The reaction mixture was then stirred for 1 hour, and the precipitate was collected by filtration. The precipitate was washed with 90 ml of isopropanol and then with 90 ml of ethyl acetate, and then dried to obtain 76 g (90%) of the hydrochloride of the target compound.
(1) 融点 107.8℃(塩酸塩)
(2) 核磁気共鳴スペクトル(d6−DMSO)δ:
ppm
内部基準にTMSを用いて、60MHzで測定し
た(以下の実施例においても同じ)。(1) Melting point 107.8℃ (hydrochloride) (2) Nuclear magnetic resonance spectrum (d 6 -DMSO) δ:
ppm Measured at 60MHz using TMS as an internal standard (the same applies to the following examples).
1.75〜2.10(2H,m)
3.05〜3.35(4H,dとtの重複、J=2Hz,
J=6Hz)
4.42(1H,m)
(3) 赤外線吸収スペクトル νNujol naxcm-1:
3300,2460,1600,1340,1210
実施例 2
ピロリジン
L−プロリン90gを用いて、実施例1と同様に
行うと目的化合物の塩酸塩77.4g(92%)が得ら
れた。 1.75~2.10 (2H, m) 3.05~3.35 (4H, overlap of d and t, J=2Hz,
J=6Hz) 4.42 (1H, m) (3) Infrared absorption spectrum ν Nujol nax cm -1 : 3300, 2460, 1600, 1340, 1210 Example 2 Pyrrolidine Same as Example 1 using 90g of L-proline. When carried out, 77.4 g (92%) of the hydrochloride salt of the target compound was obtained.
(1) 融点 87〜88℃(塩酸塩)
(2) 核磁気共鳴スペクトル(d6−DMSO)δ:
ppm
1.6〜1.78(4H,m)
2.7〜2.9(4H,m)
(3) 赤外線吸収スペクトル νnaxcm-1:
3250,1350,1070
実施例 3
1,5−ジアミノペンタン
L−リジン塩酸塩20gをシクロヘキサノール
100mlに懸濁し、次いで28%ナトリウムメトキシ
ド21.2mlを加えた後、3−メチル−Δ2−シクロヘ
キセノン1mlを加えた。反応混合物を155℃で3
時間加熱撹拌した。反応終了後、反応混合物に塩
化水素4gを含むイソプロパノール溶液20mlを加
えた。次いで反応混合物より析出する析出物をろ
取した。析出物を乾燥すると目的化合物の二塩酸
塩16.3g(85%)が得られた。(1) Melting point 87-88℃ (hydrochloride) (2) Nuclear magnetic resonance spectrum (d 6 -DMSO) δ:
ppm 1.6-1.78 (4H, m) 2.7-2.9 (4H, m) (3) Infrared absorption spectrum ν nax cm -1 : 3250, 1350, 1070 Example 3 20 g of 1,5-diaminopentane L-lysine hydrochloride cyclohexanol
The suspension was suspended in 100 ml, and then 21.2 ml of 28% sodium methoxide was added, followed by 1 ml of 3-methyl-Δ 2 -cyclohexenone. The reaction mixture was incubated at 155°C for 3
The mixture was heated and stirred for hours. After the reaction was completed, 20 ml of an isopropanol solution containing 4 g of hydrogen chloride was added to the reaction mixture. Then, the precipitate precipitated from the reaction mixture was collected by filtration. When the precipitate was dried, 16.3 g (85%) of the dihydrochloride of the target compound was obtained.
(1) 融点 255〜257℃(二塩酸塩)
(2) 核磁気共鳴スペクトル(d6−DMSO)δ:
ppm
1.45〜1.95(6H,m)
2.65〜3.30(4H,m)
8.20(4H,s)
(3) 赤外線吸収スペクトル νNujol naxcm-1:
3350,1600
実施例 4
(−)−1−アミノ−2−プロパノール
L−トレオニン35.7g、シクロヘキサノール
180mlおよびΔ2−シクロヘキセノン1.8mlを用い
て、実施例1と同様に行い、シユウ酸で処理する
と目的化合物のシユウ酸塩39.6g(80%)が得ら
れた。(1) Melting point 255-257℃ (dihydrochloride) (2) Nuclear magnetic resonance spectrum (d 6 -DMSO) δ:
ppm 1.45-1.95 (6H, m) 2.65-3.30 (4H, m) 8.20 (4H, s) (3) Infrared absorption spectrum ν Nujol nax cm -1 : 3350, 1600 Example 4 (-)-1-amino- 2-propanol L-threonine 35.7g, cyclohexanol
The same procedure as in Example 1 was carried out using 180 ml and 1.8 ml of Δ 2 -cyclohexenone, and treatment with oxalic acid yielded 39.6 g (80%) of the oxalate of the target compound.
(1) 融点 140〜142℃(重シユウ酸塩)
97℃(塩酸塩)
(2) 沸点 160℃(遊離体)
(3) 比旋光度
塩酸塩 〔α〕20 D=−32.00°(C=2.925,
H2O)
重シユウ酸塩 〔α〕20 D=−22.65°(C=
2.052,H2O)
(4) 核磁気共鳴スペクトル(d6−DMSO)δ:
ppm
1.25(3H,d,=6Hz)
2.38〜2.50(2H,m)
3.6〜3.8(1H,m)
(5) 赤外線吸収スペクトル νnaxcm-1:
3350,1600,1460,1140,1050
実施例 5
β−フエネチルアミン
1−(−)−フエニルアラニン10g、シクロヘキ
サノール50mlおよび3−メチル−Δ2シクロヘキ
セノン0.5mlを用いて、実施例1と同様に行うと
目的化合物の塩酸塩8.6g(90%)が得られた。(1) Melting point 140-142℃ (bioxalate) 97℃ (hydrochloride) (2) Boiling point 160℃ (educt) (3) Specific rotation Hydrochloride [α] 20 D = -32.00° (C = 2.925,
H 2 O) Bioxalate [α] 20 D = -22.65° (C =
2.052, H 2 O) (4) Nuclear magnetic resonance spectrum (d 6 −DMSO) δ:
ppm 1.25 (3H, d, = 6Hz) 2.38-2.50 (2H, m) 3.6-3.8 (1H, m) (5) Infrared absorption spectrum ν nax cm -1 : 3350, 1600, 1460, 1140, 1050 Example 5 β-phenethylamine 10 g of 1-(-)-phenylalanine, 50 ml of cyclohexanol and 0.5 ml of 3 -methyl-Δ2cyclohexenone were carried out in the same manner as in Example 1. 8.6 g of the hydrochloride of the target compound (90% )was gotten.
(1) 融点 217℃(塩酸塩)
(2) 沸点 197〜200℃(遊離体)
(3) 核磁気共鳴スペクトル(d6−DMSO)δ:
ppm
2.55〜2.85(4H,m)
7.22(5H,s)
実施例 6
イソブチルアミン
バリン20g、シクロヘキサノール100mlおよび
3−メチル−Δ2−シクロペンテノン1mlを用い
て、実施例1と同様に行うと目的化合物の塩酸塩
16.8g(90%)が得られた。(1) Melting point 217℃ (hydrochloride) (2) Boiling point 197-200℃ (educt) (3) Nuclear magnetic resonance spectrum (d 6 -DMSO) δ:
ppm 2.55-2.85 (4H, m) 7.22 (5H, s) Example 6 Isobutylamine If carried out in the same manner as in Example 1 using 20 g of valine, 100 ml of cyclohexanol and 1 ml of 3-methyl-Δ 2 -cyclopentenone. Hydrochloride of target compound
16.8g (90%) was obtained.
(1) 融点 158〜160℃(塩酸塩)
(2) 沸点 66〜71℃(遊離体)
(3) 核磁気共鳴スペクトル(d6−DMSO)δ:
ppm
0.92(6H,d−d,J=6Hz)
1.35〜1.70(1H,m)
2.50(2H,d,J=6Hz)
(4) 赤外線吸収スペクトル νNujol naxcm-1:
1610,1515,1405
実施例 7
3−メチルチオプロピルアミン
メチオニン10g、シクロヘキサノール50mlおよ
びΔ2−シクロヘキセノンを用いて、実施例1と
同様に行うと目的化合物の塩酸塩8.1g(85%)
が得られた。(1) Melting point 158-160℃ (hydrochloride) (2) Boiling point 66-71℃ (educt) (3) Nuclear magnetic resonance spectrum (d 6 -DMSO) δ:
ppm 0.92 (6H, dd, J=6Hz) 1.35-1.70 (1H, m) 2.50 (2H, d, J=6Hz) (4) Infrared absorption spectrum ν Nujol nax cm -1 : 1610, 1515, 1405 conducted Example 7 3-Methylthiopropylamine When the same procedure as in Example 1 was carried out using 10 g of methionine, 50 ml of cyclohexanol and Δ 2 -cyclohexenone, the hydrochloride salt of the target compound was 8.1 g (85%).
was gotten.
(1) 融点 143〜144℃(塩酸塩)
(2) 核磁気共鳴スペクトル(d6−DMSO)δ:
ppm
2.06(3H,s)
2.45〜3.15(4H,m)
3.42(1H,s)
8.30(2H,s)
実施例 8
N−メチルフエネチルアミン
N−カルボキシメチル−L−フエニルアラニン
5gをテトラリン50mlに懸濁し、次いで3−メチ
ル−Δ2−シクロヘキセノン0.5mlを加えて4時間
加熱還流した。反応終了後、反応混合物を以下、
実施例1と同様に行うと目的化合物の塩酸塩3.1
g(80%)が得られた。(1) Melting point 143-144℃ (hydrochloride) (2) Nuclear magnetic resonance spectrum (d 6 -DMSO) δ:
ppm 2.06 (3H, s) 2.45-3.15 (4H, m) 3.42 (1H, s) 8.30 (2H, s) Example 8 N-methylphenethylamine 5g of N-carboxymethyl-L-phenylalanine was added to 50ml of tetralin Then, 0.5 ml of 3-methyl-Δ 2 -cyclohexenone was added and the mixture was heated under reflux for 4 hours. After the reaction is complete, the reaction mixture is
When carried out in the same manner as in Example 1, the hydrochloride of the target compound 3.1
g (80%) was obtained.
(1) 融点 162℃(塩酸塩)
(2) 核磁気共鳴スペクトル(d6−DMSO)δ:
ppm
2.30(3H,s)
2.50〜2.58(4H,m)
7.20(5H,s)
実施例 9
3−ヒドロキシピロリジン
実施例1において、Δ2−シクロヘキセノンの
代りに2−シクロヘキシリデンシクロヘキサノン
9gを用いて、同様に反応を行うと目的化合物の
塩酸塩74.3g(88%)が得られた。(1) Melting point 162℃ (hydrochloride) (2) Nuclear magnetic resonance spectrum (d 6 -DMSO) δ:
ppm 2.30 (3H, s) 2.50-2.58 (4H, m) 7.20 (5H, s) Example 9 3-Hydroxypyrrolidine In Example 1, 9 g of 2-cyclohexylidenecyclohexanone was used instead of Δ 2 -cyclohexenone. Then, a similar reaction was carried out to obtain 74.3 g (88%) of the hydrochloride of the target compound.
物理恒数は実施例1で得られたものと同じであ
つた。 The physical constants were the same as those obtained in Example 1.
実施例 10
3,4−ジメトキシアニリン
2−アミノ−4,5−ジメトキシ安息香酸20
g、シクロヘキサノール100mlおよび3−メチル
−Δ2−シクロペンテノン1mlを用いて、実施例
1と同様に行うと目的化合物の塩酸塩16.4g(85
%)が得られた。Example 10 3,4-dimethoxyaniline 2-amino-4,5-dimethoxybenzoic acid 20
In the same manner as in Example 1 using 100 ml of cyclohexanol and 1 ml of 3-methyl-Δ 2 -cyclopentenone, 16.4 g (85 g) of the hydrochloride of the target compound was obtained.
%)was gotten.
(1) 融点 149℃(分解)(塩酸塩)
(2) 核磁気共鳴スペクトル(d6−DMSO)δ:
ppm
3.82(3H,s)
3.90(3H,s)
4.82(2H,s)
6.96(3H,s)
実施例 11
アニリン
p−アミノ安息香酸10gをテトラリン50mlに懸
濁し、次いで3−メチル−Δ2−シクロヘキセノ
ン1mlを加えて5時間加熱還流した。反応終了
後、反応混合物を以下、実施例1と同様に行うと
目的化合物の塩酸塩7.5g(80%)が得られた。(1) Melting point 149℃ (decomposition) (hydrochloride) (2) Nuclear magnetic resonance spectrum (d 6 -DMSO) δ:
ppm 3.82 (3H, s) 3.90 (3H, s) 4.82 (2H, s) 6.96 (3H, s) Example 11 Aniline 10 g of p-aminobenzoic acid was suspended in 50 ml of tetralin, and then 3-methyl-Δ 2 - 1 ml of cyclohexenone was added and the mixture was heated under reflux for 5 hours. After the reaction was completed, the reaction mixture was treated in the same manner as in Example 1 to obtain 7.5 g (80%) of the hydrochloride of the target compound.
(1) 融点 198℃(塩酸塩)
(2) 沸点 184〜186℃(遊離体)
(3) 核磁気共鳴スペクトル(d6−DMSO)δ:
ppm
3.35(2H,s)
6.35〜7.20(5H,m)
実施例 12
トリプタミン
トリプトフアン20g、シクロヘキサノール100
mlおよび1−オクテン−3−オン1mlを用いて、
実施例1と同様に行うと目的化合物の塩酸塩15.4
g(80%)が得られた。(1) Melting point 198℃ (hydrochloride) (2) Boiling point 184-186℃ (educt) (3) Nuclear magnetic resonance spectrum (d 6 -DMSO) δ:
ppm 3.35 (2H, s) 6.35-7.20 (5H, m) Example 12 Tryptamine Tryptophan 20g, cyclohexanol 100
ml and 1 ml of 1-octen-3-one,
When carried out in the same manner as in Example 1, the hydrochloride of the target compound 15.4
g (80%) was obtained.
(1) 融点 250℃(分解)(塩酸塩)
113〜118℃(遊離体)
(2) 核磁気共鳴スペクトル(d6−DMSO)δ:
ppm
3.18(4H,s)
6.90〜7.70(5H,m)
8.20(1H,s)
(3) 赤外線吸収スペクトル νNujol naxcm-1:
3320,1600,1540,1240,1180
実施例 13
3R−ヒドロキシピロリジン
実施例1において、4−ヒドロキシ−L−プロ
リンの代りに4R−ヒドロキシ−L−プロリン90
gを用いて、同様に反応を行うと目的化合物の塩
酸塩78.9g(93%)が得られた。(1) Melting point 250℃ (decomposed) (hydrochloride) 113-118℃ (educt) (2) Nuclear magnetic resonance spectrum (d 6 -DMSO) δ:
ppm 3.18 (4H, s) 6.90-7.70 (5H, m) 8.20 (1H, s) (3) Infrared absorption spectrum ν Nujol nax cm -1 : 3320, 1600, 1540, 1240, 1180 Example 13 3R-hydroxypyrrolidine In Example 1, 4R-hydroxy-L-proline90 was used instead of 4-hydroxy-L-proline.
When the reaction was carried out in the same manner using g, 78.9 g (93%) of the hydrochloride of the target compound was obtained.
(1) 融点 108℃(塩酸塩) (2)比旋光度 塩酸塩 〔α〕20 D=−7.81°(C=3.316,H2O)(1) Melting point 108℃ (hydrochloride) (2) Specific rotation hydrochloride [α] 20 D = -7.81° (C = 3.316, H 2 O)
Claims (1)
媒としてビニルケトン類を使用することを特徴と
する脱炭酸反応。1. A decarboxylation reaction of a compound having a carboxyl group, which is characterized by using vinyl ketones as a catalyst.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58131656A JPS6023328A (en) | 1983-07-19 | 1983-07-19 | Decarbonation reaction |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58131656A JPS6023328A (en) | 1983-07-19 | 1983-07-19 | Decarbonation reaction |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6023328A JPS6023328A (en) | 1985-02-05 |
JPH0410452B2 true JPH0410452B2 (en) | 1992-02-25 |
Family
ID=15063148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58131656A Granted JPS6023328A (en) | 1983-07-19 | 1983-07-19 | Decarbonation reaction |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6023328A (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5187094A (en) * | 1989-09-06 | 1993-02-16 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Method for the preparation of optically active 3-hydroxypyrrolidine derivatives |
DE4425071C2 (en) | 1994-07-15 | 1996-08-29 | Degussa | Process for the production of optically active pyrrolidines with high enantiomeric purity |
AU2788297A (en) * | 1996-05-14 | 1997-12-05 | Kyowa Hakko Kogyo Co. Ltd. | Process for the preparation of 3-hydroxypyrrolidine |
JP4665185B2 (en) * | 2000-02-09 | 2011-04-06 | 東レ・ファインケミカル株式会社 | Production method of amines |
JP2006008518A (en) * | 2004-06-22 | 2006-01-12 | Sankyo Co Ltd | METHOD FOR PRODUCING OPTICALLY ACTIVE 3-AMINO-1-tert-BUTOXYCARBONYLPYRROLIDINE |
DE102006060908A1 (en) * | 2006-12-20 | 2008-07-03 | Evonik Degussa Gmbh | Continuous process for the decarboxylation of carboxylic acids |
US20120016077A1 (en) | 2009-03-30 | 2012-01-19 | Toray Industries Inc. | Polyamide resin, polyamide resin composition, and molded article comprising same |
JP5246385B1 (en) | 2011-08-17 | 2013-07-24 | 東レ株式会社 | Method for producing crystalline polyamide resin |
JP6015494B2 (en) * | 2013-03-01 | 2016-10-26 | 宇部興産株式会社 | Method for producing alkylene polyamine |
-
1983
- 1983-07-19 JP JP58131656A patent/JPS6023328A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS6023328A (en) | 1985-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2947140C2 (en) | ||
PL165132B1 (en) | Method of obtaining optically active derivative of (2r) or (2s)3-(3-{exo-bicyclo-/2.2.1/hept-2-oxyloxy}-4-methoxy-phenyl)-glutaric acid 2s | |
HU177576B (en) | Process for preparing 2-amino-cyclohexane carboxylic acid,its amides and similar compounds | |
JPH0410452B2 (en) | ||
GB2126224A (en) | Derivatives of ???-amino alkanoic acids | |
CN1012613B (en) | Process for prepn. of quinonecarboxylic acid derivative | |
JPH0222059B2 (en) | ||
Nyc et al. | Synthesis of a biologically active nicotinic acid precursor: 2-amino-3-hydroxybenzoic acid | |
NZ229636A (en) | A process for the preparation of 2,6-dichlorodiphenylamino-acetic acid derivatives | |
EP0463944B1 (en) | Acylbenzoxazolinones, process for their preparation and pharmaceutical compositions containing them | |
JPH05255204A (en) | Production of amines | |
AU594858B2 (en) | Process and intermediates for quinolonecarboxylic acid | |
JP2567621B2 (en) | Method for ortho-cyanation of phenols or phenylamines | |
Chang et al. | New asparagine analogs | |
JPH0686431B2 (en) | Substituted tetralins, chromans and related compounds for the treatment of asthma | |
Cragoe Jr et al. | The synthesis of 3-hydroxycinchoninic acid and certain of its derivatives | |
WO2018059427A1 (en) | Method for preparing phenylalanine compound | |
JPS5892646A (en) | Benzylidene derivative | |
US20060160802A1 (en) | Peptide deformylase inhibitors | |
NORTON et al. | DL-5-Hydroxy-2-pyridinealanine, a Tyrosine Analog | |
Łukasiewicz | Reactions of trihalogenoacetic acids—II: The reaction of trichloro-and tribromoacetic acids with methylenebisamine derivatives | |
DE3300522A1 (en) | 3,3-DIALKYL AND 3,3-ALKYLENE INDOLINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME | |
Webster et al. | Tetracyano-p-phenylenediamine | |
JPH0236181A (en) | Asymmetric bisoxazolylpyridine derivative and production thereof | |
FR2487346A1 (en) | 4-OXIMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES, PROCESS FOR PREPARING THEM AND THERAPEUTIC APPLICATION THEREOF |